Tag Archive for: Data

By nearly unanimous consent artificial intelligence reached an inflection point for pharma marketers in 2023. The question of how best to take advantage of this new tool to support brands and help patients, though, remains to be seen.

MedAdNews talked to Jane Reed, director of life sciences with Linguamatics, an IQVIA company, about how pharma companies are using new AI-based technologies to advance their safety processes and other topics.

Viz.ai continues to demonstrate significant real-world evidence on the patient and economic outcomes of AI-powered care coordination; Neurolief’s neuromodulation device Relivion is approved by the Japanese Ministry of Health, Labor and Welfare; and Kanerika partners with Microsoft to build an enterprise business intelligence platform powered by Microsoft Fabric for a leading global pharmaceutical company in the United States.

The combined businesses unlock significant opportunity for clients with strategic, differentiated clinical trial recruitment, engagement and retention approaches, along with compelling creative solutions and best-in-class analytics.

How pharma companies can communicate effectively in today’s evolving marketplace and why it is the right time to embrace our humanity when engaging various stakeholders along the product, patient, and reimbursement/coverage journeys.

The appointment marks a significant milestone for PROPENSITY4, reinforcing Inizio Engage’s commitment to delivering exceptional value to its clients and positioning the company for continued success in the dynamic world of data and analytics.

Former Accenture Song and WebMD executives join network to further commitment to data and the link to actionable insights.

The company’s shares rose 3% on Monday as the market reacted to data the drugmaker presented over the weekend showing that the heart protective benefits of its popular obesity drug Wegovy are not solely due to weight loss.

This follows a late-cycle review meeting in which the regulator flagged “substantive review issues” with the New Drug Application (NDA). The FDA pointed out to Aldeyra that it does not appear to “have data to support the clinical relevance of the ocular signs to support your dry eye indication,” according to the company’s SEC filing.

The KlickRx plugin makes it quick and easy to access physician payment information using generative AI.